# Filing Detail

Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0000950123-19-008748
Filing Date
2019-08-30
Accepted
2019-08-30 17:04:20
Documents
26

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | filename1.htm | DRS/A | 3280640
2 |  | filename2.htm | EX-10.1 | 684480
3 |  | filename3.htm | EX-10.2 | 548549
4 |  | filename4.htm | EX-10.3 | 493689
5 |  | filename5.htm | EX-10.4 | 1632778
6 | GRAPHIC | g752656g00p38.jpg | GRAPHIC | 61591
7 | GRAPHIC | g752656g01r15.jpg | GRAPHIC | 131408
8 | GRAPHIC | g752656g06k36.jpg | GRAPHIC | 88319
9 | GRAPHIC | g752656g07h45.jpg | GRAPHIC | 23091
10 | GRAPHIC | g752656g10m39.jpg | GRAPHIC | 92781
11 | GRAPHIC | g752656g13m51.jpg | GRAPHIC | 77202
12 | GRAPHIC | g752656g13o50.jpg | GRAPHIC | 124495
13 | GRAPHIC | g752656g14p44.jpg | GRAPHIC | 36302
14 | GRAPHIC | g752656g14z14.jpg | GRAPHIC | 21195
15 | GRAPHIC | g752656g21p77.jpg | GRAPHIC | 81673
16 | GRAPHIC | g752656g23f14.jpg | GRAPHIC | 96266
17 | GRAPHIC | g752656g34u16.jpg | GRAPHIC | 59516
18 | GRAPHIC | g752656g41a29.jpg | GRAPHIC | 40886
19 | GRAPHIC | g752656g41w75.jpg | GRAPHIC | 123133
20 | GRAPHIC | g752656g47j52.jpg | GRAPHIC | 74742
21 | GRAPHIC | g752656g48k25.jpg | GRAPHIC | 45821
22 | GRAPHIC | g752656g59d92.jpg | GRAPHIC | 120479
23 | GRAPHIC | g752656g72h73.jpg | GRAPHIC | 60783
24 | GRAPHIC | g752656g75o68.jpg | GRAPHIC | 76078
25 | GRAPHIC | g752656g78x43.jpg | GRAPHIC | 24125
26 | GRAPHIC | g752656g85j93.jpg | GRAPHIC | 128015
| Complete submission text file | 0000950123-19-008748.txt |  | 8830833

Mailing Address 117 AVENUE DE LUMINY BP 30191 MARSEILLE I0 13009
Business Address 117 AVENUE DE LUMINY BP 30191 MARSEILLE I0 13009 33430303030
Innate Pharma SA (Filer) CIK: 0001598599 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-02690 | Film No.: 191070174
SIC: 2836 Biological Products, (No Diagnostic Substances)